Answers in days,
not years.

Nura's non-invasive blood test for endometriosis shortens the path to diagnosis from 8–12 years to 3–5 days, pairing AI-driven precision medicine with care designed around women.

Join the EMMA Study

If only understanding your body were as simple as a single test.

You're closer than you think. Every answer brings clarity.

By the numbers

The cost of waiting, and the case for a better way.

0
Women affected worldwide
8–12 yrs
Average time to diagnosis today
0
Diagnostic probability, equal to surgery
3–5 days
Time to answers with Nura
Our Mission

At Nura, we refuse to accept years of uncertainty. We replace it with clarity. Through precision diagnostics, AI, and science built around women, we make answers faster, safer, and kinder.

About Nura
Real science. Real change.

Shortening a journey that once took years.

For too long, a diagnosis meant 8 to 12 years of pain, dismissal, and invasive surgery. Nura reads AI-optimized biomarkers from a single blood draw to reach a result with up to 90% probability, equivalent to the surgical standard, without the scalpel.

How it works
A woman in soft light
A woman in warm light
Why Nura

A test built for how care
should actually feel.

01

Non-invasive blood test

Eliminate costly, invasive surgical biopsies. A simple blood draw is all it takes to begin.

02

Days, not years

AI-optimized biomarkers reach up to a 90% diagnostic probability, with results in 3 to 5 days.

03

Personalized treatment

Individualized care driven by predictive analytics, pharmacogenetics, and real-world data.

Designed around her

Care that begins with being believed.

Through the EMMA Study, a first-of-its-kind nationwide research effort, Nura is building a precision-medicine platform from biomarkers, genetics, and the lived experiences of women, so treatment fits the person, not the average.

Explore the EMMA Study
A woman at rest
A hopeful woman in golden light
“
A reliable endometriosis blood test would be a great adjunct to my infertility work-up, and I'd use it as a first-line test in my IVF protocol.
Reproductive Endocrinologist · Phoenix, Arizona
News & Research

Moving women's health forward.

Milestones, partnerships, and research from the Nura team and the EMMA Consortium.

Browse all news
Partnership

Nura + Sur180 Therapeutics

Pairing non-invasive diagnostics with next-generation, non-hormonal therapeutics, featured on AP News.

Recognition

Backed by ARPA-H

Winner of the Sprint for Women's Health and a VentureWell "30 Innovators" honoree.

Milestone

1st place, ULP REALIZE

Now a resident company at University Lab Partners' premier life-science incubator.

In good company
ARPA-H University Lab Partners VentureWell Lasa Health Dama Health Sur180 Therapeutics